Clinical Trial Update: Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and efficacy of a tissue-engineered endothelial keratoplasty for corneal endothelial decompensation conditions, inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Keratopathy
• Corneal Endothelial Decompensation
• Fuchs Endothelial Corneal Dystrophy
• Post-surgical Corneal Decompensation

Drugs mentioned

• Tissue Engineered Endothelial Keratoplasty (tissue-engineered endothelial keratoplasty)

Snippet

Sponsor: Singapore Eye Research Institute | Conditions: Mild to Moderate Corneal Endothelial Decompensation, Bullous Keratopathy | Phase 1 | Status: RECRUITING